ROYCE & ASSOCIATES LP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 137 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$18,000
-18.2%
12,344
+10.1%
0.00%
Q2 2020$22,000
+10.0%
11,209
+10.0%
0.00%
Q1 2020$20,000
-9.1%
10,189
+88.0%
0.00%
Q4 2019$22,000
-99.5%
5,420
-98.4%
0.00%
-100.0%
Q1 2016$4,070,000
+17.8%
340,589
+31.2%
0.03%
+23.8%
Q4 2015$3,455,000
-3.8%
259,589
-22.4%
0.02%
+10.5%
Q3 2015$3,591,000
+18.3%
334,374
-11.3%
0.02%
+46.2%
Q2 2015$3,035,000377,0740.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders